Johnson & Johnson Innovation – JJDC — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

TECLens inFeb 2025 · $9.3M

HealthtechStamford, US

Patrick Lopath(Chief Operating Officer)inThomas Alan Dunlap(Chief Executive Officer)Madhu Ayyagari(Chief Executive Officer)in

BoardRichel Liu(Director)Deng Mao(Director)inHirak Parikh(Director)

Co-investorsAugment Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.